Literature DB >> 11742438

2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11742438     DOI： 10.1310/AQML-UABK-5LLB-E615

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN： 1528-4336


× No keyword cloud information.
  8 in total

1.  Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

Authors:  B Castelnuovo; E Chiesa; S Rusconi; F Adorni; M Bongiovanni; S Melzi; P Cicconi; F Tordato; L Meroni; T Bini; A d'Arminio Monforte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-21       Impact factor: 3.267

Review 2.  HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.

Authors:  Ryan J Sullivan; Liron Pantanowitz; Corey Casper; Justin Stebbing; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

3.  Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.

Authors:  Gabriel Chamie; Maurizio Bonacini; David R Bangsberg; Jack T Stapleton; Christopher Hall; E Turner Overton; Rebecca Scherzer; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-01-10       Impact factor: 9.079

4.  Clinical variables identify seronegative HCV co-infection in HIV-infected individuals.

Authors:  Ajay R Bharti; Scott L Letendre; Tanya Wolfson; David Clifford; Ann C Collier; Benjamin Gelman; Justin McArthur; Christina Marra; Allen McCutchan; Susan Morgello; David Simpson; Ron J Ellis; Igor Grant
Journal:  J Clin Virol       Date:  2011-09-15       Impact factor: 3.168

5.  Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.

Authors:  Sylvie Deuffic-Burban; Elena Losina; Bingxia Wang; Delphine Gabillard; Eugène Messou; Nomita Divi; Kenneth A Freedberg; Xavier Anglaret; Yazdan Yazdanpanah
Journal:  Eur J Epidemiol       Date:  2007-09-08       Impact factor: 8.082

Review 6.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients.

Authors:  Meja Rabodonirina; Philippe Vanhems; Sandrine Couray-Targe; René-Pierre Gillibert; Christell Ganne; Nathalie Nizard; Cyrille Colin; Jacques Fabry; Jean-Louis Touraine; Guy van Melle; Aimable Nahimana; Patrick Francioli; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

8.  Vaccination in patients with HIV infection.

Authors:  Todd D Gleeson; Mark R Wallace; Sybil A Tasker
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.663
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.